Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality

被引：0
作者：
Montserrat Vera-Llonch
Derek Weycker
Andrew Glass
Sue Gao
Rohit Borker
Angie Qin
Gerry Oster
机构：
[1] Policy Analysis Inc (PAI),
[2] Kaiser Permanente Northwest,undefined
[3] Amgen Inc,undefined
来源：
BMC Cancer | / 11卷
关键词：
Cost; metastatic breast cancer; chemotherapy; burden of illness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Medical costs associated with metastatic breast cancer in younger, midlife, and older women
    Trogdon, Justin G.
    Baggett, Christopher D.
    Gogate, Anagha
    Reeder-Hayes, Katherine E.
    Rotter, Jason
    Zhou, Xi
    Ekwueme, Donatus U.
    Fairley, Temeika L.
    Wheeler, Stephanie B.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (03) : 653 - 665
  • [42] Medical costs associated with metastatic breast cancer in younger, midlife, and older women
    Justin G. Trogdon
    Christopher D. Baggett
    Anagha Gogate
    Katherine E. Reeder-Hayes
    Jason Rotter
    Xi Zhou
    Donatus U. Ekwueme
    Temeika L. Fairley
    Stephanie B. Wheeler
    Breast Cancer Research and Treatment, 2020, 181 : 653 - 665
  • [43] Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy a longitudinal study
    Harvie, MN
    Howell, A
    Thatcher, N
    Baildam, A
    Campbell, I
    BRITISH JOURNAL OF CANCER, 2005, 92 (04) : 673 - 680
  • [44] Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy – a longitudinal study
    M N Harvie
    A Howell
    N Thatcher
    A Baildam
    I Campbell
    British Journal of Cancer, 2005, 92 : 673 - 680
  • [45] Systemic chemotherapy for metastatic breast cancer
    Yannan Zhao
    Biyun Wang
    OncologyandTranslationalMedicine, 2015, 1 (05) : 226 - 232
  • [46] Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer
    Christoph C. Zielinski
    Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 33 - 36
  • [47] Treatment choices for second-line chemotherapy of metastatic breast cancer
    Zielinski, CC
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 : S33 - S36
  • [48] Role of adjuvant chemotherapy in the choice of chemotherapeutic treatment of metastatic breast cancer
    Lopez, M.
    Di Lauro, L.
    Viola, G.
    Conti, F.
    Foggi, P.
    Vici, P.
    CLINICA TERAPEUTICA, 2009, 160 (06): : 489 - 497
  • [49] Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan
    Lin, Yu-Ju
    Kuo, Chun-Nan
    Ko, Yu
    BREAST, 2021, 57 : 18 - 24
  • [50] Metronomic Chemotherapy for Metastatic Breast Cancer
    Krajnak, Slavomir
    Battista, Marco J.
    Hasenburg, Annette
    Schmidt, Marcus
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 10 - 17
12345